CMV infections after hematopoietic stem cell transplantation
β Scribed by Ljungman, P
- Book ID
- 109839270
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 87 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Addition of in vivo alemtuzumab to the conditioning regimen enabled 2β or 3βlocusβmismatched hematopoietic stem cell transplantation with an acceptable incidence of graftβversusβhostβdisease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivati
A 43-year-old man with acute lymphoblastic leukemia was treated with three cycles of hyper-CVAD (hyper fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone) followed by allogeneic hematopoietic stem cell transplantation (HCT) from a sibling. Six months later, the patient presen